home / stock / pdsb / pdsb quote
Last: | $ |
---|---|
Change Percent: | -25.84% |
Open: | $1.30 |
Close: | $1.32 |
High: | $1.36 |
Low: | $1.29 |
Volume: | 1,249,860 |
Last Trade Date Time: | 02/12/2020 04:40:39 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $1.30 | $1.32 | $1.36 | $1.29 | 1,249,860 | 02-12-2020 |
$ | $2.04 | $1.78 | $2.05 | $1.72 | 190,399 | 02-11-2020 |
$ | $2.4001 | $2.03 | $2.445 | $2.03 | 141,998 | 02-10-2020 |
$ | $2.66 | $2.28 | $2.66 | $2.22 | 143,894 | 02-07-2020 |
$ | $2.32 | $2.64 | $2.70 | $2.21 | 69,111 | 02-06-2020 |
$ | $2.56 | $2.31 | $2.60 | $2.11 | 130,641 | 02-05-2020 |
$ | $2.5197 | $2.52 | $2.59 | $2.402 | 15,181 | 02-04-2020 |
$ | $2.33 | $2.47 | $2.57 | $2.33 | 15,059 | 02-03-2020 |
$ | $2.50 | $2.47 | $2.64 | $2.38 | 69,090 | 01-31-2020 |
$ | $2.56 | $2.62 | $2.65 | $2.41 | 38,055 | 01-30-2020 |
$ | $2.6855 | $2.5528 | $2.70 | $2.455 | 47,121 | 01-29-2020 |
$ | $3.00 | $2.61 | $3.01 | $2.61 | 97,131 | 01-28-2020 |
$ | $2.62 | $2.85 | $2.95 | $2.62 | 95,319 | 01-27-2020 |
$ | $3.10 | $2.77 | $3.10 | $2.64 | 40,947 | 01-24-2020 |
$ | $2.60 | $3.03 | $3.03 | $2.45 | 36,762 | 01-23-2020 |
$ | $2.30 | $2.64 | $2.701 | $2.30 | 33,278 | 01-22-2020 |
$ | $2.51 | $2.36 | $2.58 | $2.33 | 19,293 | 01-21-2020 |
$ | $2.51 | $2.54 | $2.6381 | $2.51 | 20,206 | 01-20-2020 |
$ | $2.51 | $2.54 | $2.6381 | $2.51 | 20,206 | 01-17-2020 |
$ | $2.52 | $2.50 | $2.64 | $2.35 | 14,344 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
PDS Biotechnology Corporation Company Name:
PDSB Stock Symbol:
NYSE Market:
PDS Biotechnology Corporation Website:
Unique mechanism of action of the combination of PDS01ADC and Versamune ® results in 3-year survival of 75% and 75% overall response rate in advanced head and neck cancer trial As a result, Company to focus late-stage clinical strategy on triple combination of PDS01ADC,...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines ba...